Influence of coagulation factors on intrinsic thrombin generation

被引:3
作者
Stief, Thomas W. [1 ]
Otto, Stefanie [1 ]
Renz, Harald [1 ]
机构
[1] Univ Hosp, Dept Clin Chem, D-35033 Marburg, Germany
关键词
antithrombin III; factor II; factor IX; factor VIII; intrinsic coagulation activity assay; thrombin;
D O I
10.1097/MBC.0b013e32801297cd
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The intrinsic coagulation activity assay (INCA) is a new thrombin-generation test that imitates the intrinsic pathway of blood coagulation. The aim of the, present study was to investigate the influence of the main coagulation factors on the INCA. The INCA was performed with citrated plasma samples supplemented with different amounts of fibrinogen. The INCA and activated partial thromboplastin time determination were performed with factor-depleted plasmas and with mixtures of depleted plasmas with normal plasma. Supplemented purified fibrinogen resulted in a decrease of intrinsic thrombin generation (50% inhibitory concentration = 0.8 g/l). The INCA depends on the intrinsic factors (factors VIII, IX, XI and XII) and on the factors of the common pathway (factors II, V and X): for normal thrombin generation, at least about 50% of normal factor II is necessary. For the majority of factors, the sensitivity of the INCA appears to be approximately one order of magnitude better than that of the activated partial thromboplastin time.
引用
收藏
页码:67 / 71
页数:5
相关论文
共 16 条
[1]   Thrombin generation for the control of heparin treatment, comparison with the activated partial thromboplastin time [J].
Al Dieri, R ;
Alban, S ;
Béguin, S ;
Hemker, HC .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2004, 2 (08) :1395-1401
[2]   New insights into how blood clots: Implications for the use of APTT and PT as coagulation screening tests and in monitoring of anticoagulant therapy [J].
Bajaj, SP ;
Joist, JH .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1999, 25 (04) :407-418
[3]   Thrombin generation time is a novel parameter for monitoring enoxaparin therapy in patients with end-stage renal disease [J].
Brophy, DF ;
Martin, EJ ;
Gehr, TWB ;
Best, AM ;
Paul, K ;
Carr, ME .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 (02) :372-376
[4]   Evaluation of thrombin generating capacity in plasma from patients with haemophilia A and B [J].
Dargaud, Y ;
Béguin, S ;
Lienhart, A ;
Al Dieri, R ;
Trzeciak, C ;
Bordet, JC ;
Hemker, HC ;
Negrier, C .
THROMBOSIS AND HAEMOSTASIS, 2005, 93 (03) :475-480
[5]   Thrombin generation assays:: accruing clinical relevance [J].
Hemker, HC ;
Al Dieri, R ;
Béguin, S .
CURRENT OPINION IN HEMATOLOGY, 2004, 11 (03) :170-175
[6]  
HEMKER HC, 1995, THROMB HAEMOSTASIS, V74, P134
[7]   Reliability of the thrombin-generation assay in frozen-thawed platelet-rich plasma [J].
Lippi, Giuseppe ;
Salvagno, Gian Luca ;
Montagnana, Martina ;
Guidi, Gian Cesare .
CLINICAL CHEMISTRY, 2006, 52 (09) :1827-1828
[8]   The measurement of low levels of factor VIII or factor IX in hemophilia A and hemophilia B plasma by clot waveform analysis and thrombin generation assay [J].
Matsumoto, T ;
Shima, M ;
Takeyama, M ;
Yoshida, K ;
Tanaka, I ;
Sakurai, Y ;
Giles, AR ;
Yoshioka, A .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 (02) :377-384
[9]  
Mosesson MW, 2003, THROMB HAEMOSTASIS, V89, P9
[10]  
Ofosu Frederick A., 1996, Seminars in Thrombosis and Hemostasis, V22, P303, DOI 10.1055/s-2007-999024